CelluVir Mission
Antiviral immune response
Our mission is to improve global health by making affordable and easy-to-use diagnostic tools. We focus on the development and application of simple methods to assess the maintenance and the memory of antiviral cellular immunity in a personalized approach.
Value Proposition
Our innovative Skin patch technology allows for non-invasive, painless testing of cellular immunity against viruses, including our patented test for SARS-CoV-2. Our diagnostic tool can help determining the further need for vaccination or drug treatment.
Problems to Solve
Viral diseases pose a significant threat to global health, and the SARS-CoV-2 pandemic has highlighted the need for innovative diagnostic tools to detect and manage antiviral immunity. Current diagnostic methods are often invasive, unreliable, and expensive, leading to delayed diagnosis and potentially unnecessary immunization. Moreover, no affordable diagnostic methods are available for assessing antiviral cellular immunity, either in reconvalescent or vaccinated individuals.
Solution -CoviCell Skin patch
Background
The following institutes played an essential role in providing a professional and supportive background for our inventors in the development of the CoviCell Skin patch:
Semmelweis University
Research Centre for Natural Sciences
National Korányi Institute of Pulmonology